Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Multiple Sclerosis, Relapsing-Remitting
Clinical Trial
NCT00235989Last updated: 12/24/2025
Colorectal Neoplasms
Pneumonia, Bacterial
Overactive Bladder
Chronic Kidney Disease
Oral Contraceptive